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fhe physiologic Basis for Nutritional Support in Hepatic Failure

John J. Fath, MD, MPH*

Hepatic failure is often perceived as a unldimensional progression from near normal clinical function
(Child's class A) to overt clinical failure (Child's class C). As this view fails to distinguish berween
patients who are capable of using exogenous protein and those who cannot, it hinders the nutritional
support team in determining protein supplementation. This report addresses the physiologic basis for
variable findings in hepatic failure and proposes a .simple definition of hepatic fadure based upon
ability lo utilize amino acids. (Henry Ford Hosp MedJ 1990:38:229-34)

hronic hepatic failure is often viewed as a unidimensional
failure of hepatic organ function related solely to loss of hepatic parenchymal volurae. While perhaps correct for certain aspects of hepatic function, this view fails to account for the coraplex nature ofthe hepatic role in the body's responses to different metabolic or nutritional settings. Such a liraited view may
lead to inappropriate restriction of protein intake. What follows
is an attempt to place the coraplex nature of hepatic failure into
a framework of metabolic responses. By depicting the hepatic
role in the body's normal responses to certain metabolic or nutridonal settings, it hopefully will be easier to understand the
body's responses to the failing liver.

C

Hepatic Use of Nutritional Substrates
The Hver has many different pathways available for the metabohsra of any particular substrate. How it uses substrates depends on the horraonal control over these pathways (1). In general, the pathways tend to lead either to storage or acute use. The
carbohydrate pathways, potentially the siraplest, become complex as the available precursors change. For example, in the fed
state, sufficient glucose is available to allow glycogen formation
and to supply glucose for peripheral use. Fasting leads to glycogenolysis, and glucose presenting to the liver via the arterial or
portal system during fasting tends to be exported for peripheral
use. In starvation, precursors for glucose production becorae
scarce, and araino acids (from protein degradation) or glycerol
(from fat metabolism) becorae the raain gluconeogenic precursors. The pathways for fatraetabolisraare sirailarly controlled
hut maderaorecomplex by the need to coordinate formation of
hoth triglyceride and transport proteins to allow storage at the
peripheral lipocytes.
Control over protein metabolism is different in that there is no
'storage site for protein coraparable to glycogen or fat. Muscle
hecomes a repository of intracellular free araino acids and expendable protein (2,3). In fed states,rauscletakes up free araino
"eids. Muscle protein israadenot for storage but as a response to
e'^ercise. In injury or sepsis, amino acids are released and raus-
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Table
Relative Rates of Metabolic Processes in Sepsis/Injury,
Starvation, and Hibernation
Sepsis/Injury

Metabolic Slale
Mu.scle protein catabolism
Vi,sceral protein catabolism
Gluconeogenesis
Lipolysis
Protein synthesis

-l-l+

Starvation
+

-I-++

-l-l-t-

-1-

-I-++

++

-1-

Hibernation

—
—
-1-

++-I-I-

Note: The number of "-(-" markings indicate the rate of thai process relative to the other
metabolic stales. The "—markings signify an increase in lean body mass.

cle protein is catabolized (Table). In starvation, organ protein
frora the kidney, gut, and liver is catabolized to a greater extent
while rauscle protein is catabolized at a slower rate (1). The
liver's role in these raetabolic states is govemed by coraplex
hormonal interactions which are not yet well understood.

Normal Metabolic States
The various alternate pathways for hepatic substrate are present to allow adaptation to the different environmental settings
organisms face. One exaraple is the fed versus fasting state. Fed
aniraals use nutrients for current needs and shunt the remainder
to storage. Fasting animals use glycogen and free amino acids
and begin mobilizing fat stores. A shift away frora a glucose-intensiveraetabolisradoes not occur until starvation ensues.
Starvation and hibernation are two examples of long-term
raetabolic states (4). Both are fat-dependent and attempt to spare
rauscle protein. Hibernation actually increases lean body mass
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as araeansto prevent urea forraation. The metabolic states of
starvation and hibernation both tend to preserve stores as rauch
as possible.
In contrast, the response to fear is a mobilization state (5).
Glucose and amino acids are rapidly released to provide acute
energy for brain andrauscle.The response to provide energy for
short-term muscle reaction in tiraes of extraordinary need is
shifted after injury to provide short-terra energy for reparative
processes (1,6). The response to injury is not a conservative one
and never shifts to a fat-basedraetabolisra.Although fat is used,
glycerol and araino acids are necessary to maintain gluconeogenesis. Muscle protein catabolism fuels gluconeogenesis and
provides for hepatic synthesis of acute phase proteins. The response to injury and sepsis becoraes a nitrogen-wasting raetabolisra at the expense ofrauscleprotein despite high hepatic synthesis rates (3,5). It is also directed toward an anaerobic reparative process at the local wound level. The systeraic effects of
horraonalraessengersreleased to guide the local repair process
may partially explain the oxidative metabolic "defect" (7) seen
in sepsis and hepatic failure. From the standpoint of hepatic involveraent in such processes, its capacity to re.spond is large.
Hepatic response is likely related to the level of hormonal stimulation rather than to parenchymal mass.

centrations of portal substrates to levels tolerated by the orgg^j
of systemic circulation. At other times the liver controls the sy^.
temic levels of a substrate by synthesis. Systemic glucose levejj
are a common example of hepatic control, but levels ofraostcir.
culating substrates are controlled by the liver in one way or gj,.
other. Hepatic control over plasraa levels of substrates provides
feedback to systeraic horraonal control systeras. Failure of tiij
liver to control portal circulation output can alter the body'j
metabolic state by dismpting these feedback mechanisras.

Immune Functions
The liver can exertraetaboliccontrol indirectly through Knupf.
upf.
fer cell interactions. Iraraunologic functions ofthe Kupffer cell
systera include local control over portal systera bacteremias and
sorae processing of peritoneal and systemic antigens. White cell
mediated activation of the stress response can thus affect tts;
liver through local or systemic action (8). Laboratory data support a direct Kupffer cell action upon adjacent hepatocytes, witb
potentially destructive or inhibitory action as well as activation
of stressraetabolisra(9). The potential systemic effects of portal
blood shunting away frora the Kupffer cell systera have not been
well studied but could be responsible for activating the iramune
systera on a systeraic level.

Control Over Metabolism

Testing Hepatic Function

The orchestration of these various raetabolic states is controlled by several systeras which are responding to stirauli on
different fronts (I). The portal systera allows siraple feedback
control over insulin and glucagon release during cycles of feeding or fasting. The triggers for hibemation are not clear but raost
likely are related to steroid horraonal control. The neuroendocrine axis initiates the flight/fight response (5). Hepatic involveraent in the variousraetabolicresponses requires sensitivity to
raultiple control stimuli (I). The liver has a direct autonoraic
nervous system innervation. Direct neural respon,ses are immediate as in the "flight or fight" response. Arterial plasma brings
classic neuroendocrine hormones, catecholaraines, and lyraphokines. Portal flow brings pancreas and gut horraones as well
as lyraphokines frora the extensive gut lymphatics. This endocrineraetabolicresponse provides for long duration responses
as in septic states or tissue injury (8). The hepatic response to
any hormone can be affected by raany factors including body
teraperature, hepatic energy state, precursor supply, receptor
status, hepatic blood flow, and the balance of other horraones
acting concurrently. Although the layers of control are coraplex
and readily perturbed, the parenchyraal metabolic raachinery
has a large capacity and requires extensive cell loss before the
basicraetabolicfunctions cease.

Current hepatic function tests do not assess the various control systems which influence hepatic function. Determining how
well the liver is performing in any metabolic state is difficult
without knowing the degree of stimulus for any single function.
Some hepatic functions are not extensively supported and, lilce
ethanolraetabolisra,are readily saturated (10). Other functions
are concentration gradient phenoraena and can be altered by
siraple changes in hepatic blood flow (11). Detoxification of
sorae drugs is linearly related to blood flow or parenchymal
mass. Several clearance tests have been purported to be for he'
patic function, but they either lack specificity or fail to distinguish between parenchyraalraassand blood flow changes. Clinically, such tests do not provide inforraation regarding hepatic
ability to recover frora or tolerate stress. Whileraetabolicclearance tests, such as plasraa amino acid clearance, have defflo^
strated good correlation with hepatic function in severe stress
(12-15), they do have limitations. For example, plasma amino
acid clearance is useful only in the late stages of hepatic failuf^'
Because of the varied functions of the liver, any single test is i *
likely to provide all the information that clinicians may requf'
for an accurate prognosis.

Control Over Portal System
The liver is not a passive component in the network of raetabolic control. It commands the venous exit site frora the portal
system and effectively isolates portal venous circulation from
systemic circulation. Appropriate interaction between the two
environments, portal and systeraic, is dependent upon hepatic
function. Sometiraes hepatic function entails reducing high con-
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Complex Versus Basic Functions
Complex functions, such as those described above, repn•eseni
the controlling aspects of hepaticraetabolisra.Basic functio
such as gluconeogenesis, protein synthesis, araino acid uptal"'
and triglyceride production, are the controlled functions. SucM
categorization of functions has value in that the capacity for''^
sic hepatic functions is well supported within the parenchyi"^
mass and requires extensive loss of parenchyma to reach
gerous levels.

Nulrilional Suppon in Hepatic Failutr

250
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•

Child's C
Died

(A)
} Central plasma amino acid clearance rates of patients
undergoing operative procedures. Patients are elassified by
Child's class and by their survival postoperatively. Note that
survival was related to an increased ability to use amino acids
as the clinical hepatic failure worsened. (Data from Pearl et al
l!2].)
A third category, intermediate functions, includes functions
that are neither directly involved in stress metabolism nor a part
ofthe controlling process. For exaraple, functions such as drug
detoxification and bileraetabolisraraaybe sensitive to changes
in blood flow or enzyme induction (II), but they are not necessarily the determining factors in survival when altered during
stress metabolism.

Assessment of Hepatic Function
Most liver function tests that clinicians use do not assess the
capacity ofthe basic hepaticraetabolicsystem. As a result, tests
such as serum bilirubin or hepatic enzyraesraaysuggest hepatic
failure when the parenchyraalraassis adequate for raetabolic
function. Pearl et al (12) reported that patients with the sarae
Child's classification often hadraarkedlydifferent capacities to
use amino acids. (Child's classification is a clinical categorization of patients based upon presence of ascites and hepatic encephalopathy, the patient's nutritional status, and values for serum bilirubin and alburain. A Child's class C patientraayhave
uncontrolled ascites,rausclewasting,raarkedhepatic encephalopathy, serura bilirubin > 3.0 g/dL, and serura alburain < 3.0
g/dL.) These authors noted that postoperative survival related
"tore to the body's ability to use araino acids rather than the patient's Child's classification (Fig I). What has "failed," then, is
the control overraetabolisra.Instead of the standard metabolic
patterns, a differentraetabolisraappears due to alterations in the
"lore complex control systems.
The cause of such failure is not known, but several raechatisms are possible. Shunting of portal blood to a systeraic pool
"•ay allow toxins, usually cleared by hepatic systeras, to stirau'ate peripheral iraraune cells and set up a systemic stress re•''Ponse. Portal horraones which norraally are cleared by the liver
"lay pass to the systeraic circulation and alter the horraonal bal^'"^e. In tum, peripheral horraonal instructions raay be interP'^eted incorrectly by the corapromised liver. Complex func-

'"fy Ford Hosp Med J—Vol 38. No 4. 1990

mg Nl 9 hr/ kg

(B)
Fig 2—Comparison between patients with hepatic cirrhosis and
control subfects at two different dietary compositions: A) 1 g
protein/kg/day; B) 0.5 g protein/kg/day. (Data from Swart et al
[20].)

tions of the liver raay be related to parenchyraal mass, yet it is
more likely that the balance of hormonal control from portal and
systemic input becoraes deranged. The result is a maladaptive
metabolism that approximates the stress response in its heraodynaraic characteristics (16-18) and in the hypermetabolic protein
wasting that occurs. Clinically, the ability to estiraate the level
ofraetabolicstress and changes in the controlling milieu is currently limited to nitrogen excretion studies (19). Hormonal and
amino acid levels have been used in categorization schemes but
are seldom available clinically.

Definition of Two Stages of Hepatic Failure
The above definitions allow breakdown of hepatic failure into
two siraple stages: early hepatic failure and late hepatic failure.
Early hepatic failure involves progressive irapairraent of complex and intermediate functions. Alteration of the complex liver
functions leads to a stress-styleraetabolisra.Swart et al (20)
have demonstrated increased protein synthesis and rapid protein
breakdown in patients with hepatic failure when compared to
control subjects. This increase was noted in patients on protein
supplemented diets (1 g/kg) (Fig 2A) as well as in those on protein-restricted diets (Fig 2B). These data suggest thatraanypa-
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Fig 3—Plasma levels of aldosterone in patients with hepatic
cirrhosis and control subjects. Note the plasma level response
to albumin Infusion. (Data from Wong etal [24].)

tients with hepatic failure actually have increa.sed hepatic protein metabolism when corapared to patients with normal hepatic
function. Clinical assessment of araino acid clearance deraonstrates increased clearance by patients with hepatic cirrhosis
corapared to nonstressed patients (12,15). A shift to a metabolism that is less effective at oxidative functionraakestotal body
oxidativeraetabolisraflow-dependent(18). Failure to raaintain
such increased basic functions bodes poorly for the patient, indicating the beginning of late hepatic failure. Early hepatic failure
includes decreased ability to control complex functions and a
shift to stress-styleraetabolisra.Such araetabolisraactually increa.ses the rate ofraanybasic functions but does so in the context of a peripheral protein-wasting stress-style raetabolisra.
Prolongation of such araetabolisraleads to many of the signs
attributed to chronic hepatic failure. Decreased bile synthesis
leads to poor fat absorption and loss of calories and fat-soluble
vitamins (21-23). Protein synthesis, although increased, is accompanied by a rapid proteolysis (20). Muscleraassis consumed, as in sepsis, and alburain levels fall. Hormonal irabalances are seen, with high aldosterone and renin levels (24) (Fig
3). Sodiura and water dynaraics shift, leading to a.scites formation.

Nutrition During Early Hepatic Failure
Complications during early hepatic failure areraainlydue to
the effects of malnutrition and portal hemodynaraics (25-28).
Nutritional support of patients during this period is essential to
prolonging survival. Althoughraostconcur about suppleraentation of calories in the forra of carbohydrate and fat, much controversy exists over the use of protein. Two areas of protein
metabolism complicate our understanding of the process. It is
known that the liver handles amino acids differentially (2).
Branched-chain amino acids are readily metabolized by both
hepatic and nonhepatic cells. In the altered metabolism of stress
and hepatic failure, branched-chain amino acids may enter the
ceUular energy pathways and be oxidized (7). Sorae araino acids, which are used more for protein synthesis and less for oxidative energy, are often present in higher concentrations than in
normal plasma. These high levels indicate that protein break-
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down releases amino acids faster than they can be used, whereas
the low plasraa levels of branched-chain araino acids indicate
that their oxidation is delivery-dependent. This differential me
tabolism makes more apparent the rationale for high quantitiej;
of branched-chain araino acids and lower quantities of aromatic
araino acids in the nutrirional suppleraentation of patients wiiij
hepatic failure. Supporting the energyraetabolisraof both pgj:
ripheral cells and hepatocytes aids in protein synthesis but rnm
not decrease the catabolic activity. Protein support does alio*
positive nitrogen balance to occur. Sorae studies suggest thf
branched-chain araino acid enriched solutions support nitrogej
retention better than standard amino acid content nutritional solutions (29.30). The role of branched-chain araino acid solutions
in reducing encephalopathy is less clear (19,31-38).
Gutraetabolisraof protein raay produce different portal substrates depending on the type and amino acid mix of the proteit
Blood or red meat protein is pooriy tolerated by patients withi
hepatic failure; equal araounts of nitrogen delivered as pl^l
protein arerauchbetter tolerated (33). Protein suppleraentation
studies are still incoraplete and no conclusive data have bees
obtained. Whileraanystudies support the use of special amino
acidraixturesfor patients with hepatic failure, others do not {\%
31-38). What should be apparent is that the liver's basic metobolic function is still intact enough to use calories and protein,
because it is still producing more protein than a nonstresseJ
liver. In an atterapt to reduce the coraplications of proteolysis
andraalnutrition,patients should receive protein dietary supplements. The type of suppleraentation is determinedraainlybytle
risk of encephalopathy. Sorae patients tolerate standard suppleraentation well, whereas others do not. For the latter group, tbe
cost and risks of high branched-chain solutions are justified.
When branched-chain araino acid forraulations are used, a carbohydrate-based nutrition plan should be followed. Some ofthe
conflicting reports regarding efficacy of branched-chain amino
acid preparations may be related to u.se of fat-based plans (19).

Late Hepatic Failure
In the above staging system, eariy hepatic failure is depicted
as that period when the coraplex and intermediate hepatic functions are impaired, yet the capacity of the liver to perform the basic functions is actually stimulated. Late hepatic failure begins
when the liver's capacity to perforra basic functions deteriorates. Unless the events responsible for deterioration to late hepatic failure (such as sepsis or toxins) can be reversed, an inexO'
rable progression of coraplications leading to death will ensue^
Hypoglyceraia andraarkedhyperarainoacideraia are poor prog'
nostic signs. What confounds the study of hepatic failure is
ability of sepsis, hepatitis, dietary indiscretion, or gastrointesO
nai bleeding to push a patient into the late stage of hepatic tdi
ure. Treatraent of the inciting event can often lead to recoveCj
(39). Acute fulminant hepatic failure is an exaraple of a rap
progression frora early to late hepatic failure which can sonj^^
tiraes be reversed. Single laboratory tests becorae useless m
terraining outcorae. Death from hepatic failure is seldom soiw
related to loss of hepatic function. In chronic hepatic fai'" '
complications of portal hypertension and infection can o^
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Ipr patients at any stage, and routine surgical procedures are
* pfly tolerated. Such uncontrolled variablesraakeprognosis
P° ^pon hepatic function tests difficult. Appropriate assess^ of hepatic function should include a stress level index, a
^ atic blood flow index, and an index of the parenchymal metboli'- response. However, such a tripartite test has not been
died and would still be subject to the vagaries of reversible
^'^rtiuli such as sepsis or hepatitis. Before conclusive data can be
u.oined nutritional studies must be able to isolate and raonitor
obta'"^ '
. .
. . ,.
hepatic function in response to nutntional input.

Summary
The liver is a complex organ which has acquired several layers of functions during its evolution. Theraetabolicaspects of
hepatic funcrion are crucial regarding patient survival following
injuryor infection. The liver's metabolic functions are under ex(grisive control by several systeras which are responsive to different stirauli. In early hepatic failure, complex hormonal control is altered into a maladaptive state of stimulated basic functions in a pattern sirailar to the response to sepsis and injury. Intermediate functions which are sensitive to loss of parenchyraal
mass and changes in blood flow or which require support of specific protein synthesisraaybecorae progressively irapaired. The
metabolic response to early hepatic failure is termed raaladaptive because it leads to a progressiveraalnutritiondue to extensive catabolism, irapaired absorption of nutrients, and shifts in
the patterns of protein synthesis. Such a state dirainishes the
body's ability to tolerate additional insult frora injury, infection,
or hemorrhagic shock. Nutrition must be supported, yet differential handling of proteins and the risk of encephalopathy demand caution during nitrogen suppleraentation. Although studies are not conclusive, a prudent approach to nutrition in early
hepatic failure would include trials of standard forraulas, reserving branched-chain supplemented forraulas for those whose predilection to encephalopathy precludes the use of standard diets.
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